TINJAUAN PUSTAKA: PATOGENESIS DAN DIAGNOSIS SISTEMIK LUPUS ERITEMATOSUS

May Fanny Tanzilia, Betty Agustina Tambunan, Desak Nyoman Surya Suaemitria Dewi

Abstract


Sistemik Lupus Eritematosus (SLE) adalah penyakit inflamasi autoimun kronis dengan manifestasi klinis yang luas. Perjalanan penyakit dan prognosis dari SLE pun juga beragam. Faktor lingkungan, imunologi, hormonal, dan genetik diketahui memegang peranan dalam perkembangan SLE. Penyakit SLE lebih banyak menyerang wanita terutama usia produktif. Patogenesis SLE mengikutsertakan berbagai sel dan molekul yang berperan pada proses apoptosis, respons imun innate dan adaptif. Diagnosis SLE ditegakkan berdasarkan manifestasi klinis, yang harus memenuhi 4 dari 11 kriteria American Rheumatology Association (ARA) (1997), dan pemeriksaan laboratorium. Terapi SLE bersifat individual berdasarkan manifestasi klinis yang dialami pasien, aktivitas penyakit dan derajat keparahan penyakit serta komorbiditas. Prognosis SLE bervariasi mulai dari ringan hingga berkembang cepat menjadi berat disertai kegagalan multiorgan bahkan kematian. Studi pustaka ini diharapkan dapat memberikan informasi lebih mendalam mengenai patogenesis dan cara menegakkan diagnosis SLE sehingga dapat menjadi dasar dalam pengembangan penelitian mengenai SLE di masa yang akan datang.

Keywords


Lupus, SLE, autoimun

References


Perhimpunan Reumatologi Indonesia. (Online) 2011. Diagnosis dan pengelolaan lupus eritematosus sistemik. www.reumatologi.or.id. [diakses tanggal 15 Juni 2016].

Bertias G, Cervera R, Boumpas DT. (Online) 2012. Systemic lupus erythematosus: pathogenesis and clinical features. Eular. 20:476-505; https://www.eular.org/myuploaddata/files/sample%20chapter20_mod%2017.pdf [diakses tanggal 15 Juli 2016].

Souirti Z, Lahlou M, Ouali OE, Chtaou N, Aarab C, Ghazouani FE, et al. 2013. Neuropsychiatric systemic lupus erythematosus. Open Journal of Rheumatology and Autoimmune Diseases. 3:86-91.

Cozzani E, Drosera M, Gasparini G, Parodi A. 2014. Serology of lupus erythematosus: correlation between immunopathological features and clinical aspects. Autoimmune Diseases. 2014: 321359.

Maidhof W dan Hilas O. 2012. Lupus: an overview of the disease and management options. P&T: A Peer-Reviewed Journal for Formulary Management. 37(4):240-246, 249.

Anggraini NS. 2016. Lupus eritematosus sistemik. Jurnal Medula Unila. 4(4):124-131.

Mok CC dan Lau SC. 2003. Pathogenesis of systemic lupus erythematosus. Journal of Clinical Pathology. 56(7):481-490.

Lehmann P dan Kuhn A. 2005. Photosensitivity in lupus erythematosus. In: Kuhn A., Lehmann P., Ruzicka T. (eds) Cutaneous Lupus Erythematosus. Berlin: Springer. Chapter 12:161-175.

Kementerian Kesehatan RI (InfoDATIN: Pusat Data dan Informasi Kementerian Kesehatan). (Online) 2017. Situasi Lupus di Indonesia. Jakarta: PUSDATIN. www.pusdatin.kemkes.go.id. [diakses 18 Agustus 2020].

Gill JM, Quisel AM, Rocca PV, Walters DT. 2003. Diagnosis of systemic lupus erythematosus. American Family Physician. 68(11):2179-2186.

Rai DK, Upadhyaya SK, Sharma A, Kuldeep K. 2012. A case of lupus pneumonitis mimicking as infective pneumonia. IOSR Journal of Pharmacy. 2(5):11-14.

Gari AG, Telmesani A, Alwithenani R. (Online) 2012. Pulmonary manifestations of systemic lupus erythematosus. In: Almoallim H. Systemic Lupus Erythematosus. Shanghai: IntechOpen. Chapter 14;313-336. https://www.intechopen.com/books/systemic-lupus-erythematosus/pulmonary-manifestations-of-systemic-lupus-erythematosus [diakses tanggal 30 Juni 2016].

Yip YF dan Chan WKY. 2006. Acute respiratory failure in systemic lupus erythematosus. Hong Kong Journal of Paediatrics (New Series). 11:147-152.

Agrawal S. 2004. Lupus nephritis: an update on pathogenesis. Journal of Indian Rheumatology Association. 12:11-15.

Liu Y dan Anders HJ. 2014. Lupus nephritis: from pathogenesis to targets for biologic treatment. Nephron Clininical Practice. 128(3-4):224-231.

Gibson K, Goodemote P, Johnson S. 2011. FPIN’s clinical inquiries: antibody testing for systemic lupus erythematosus. American Family Physician. 84(12):1407-1409.

Muscal E dan Brey RL. 2010. Neurological manifestations of systemic lupus erythematosus in children and adults. Neurologic Clinics. 28(1):61-73.

Shankar S dan Behera V. 2014. Advances in management of systemic lupus erythematosus. Journal of Mahatma Gandhi Institute of Medical Sciences. 19:28-36.

Johns Hopkins Lupus Center. (Online) 2020. Urinalysis. Baltimore: John Hopkins Lupus Center. www.hopkinslupus.org. [diakses tanggal 11 Agustus 2020].

Bessone F, Poles N, Roma MG. 2014. Challenge of liver disease in systemic lupus erythematosus: clues for diagnosis and hints for pathogenesis. World Journal of Hepatology. 6(6):394-409.

Euroimun a PerkinElmer company insert kit. (Online) 2020. ANA diagnostics using indirect immunofluorescence. Lübeck: Euroimmun. www.euroimmun.com. [diakses tanggal 7 Agustus 2020].

Richey Monica. (Online) 2019. Understanding laboratory test and results for systemic lupus erythematosus (SLE). New York: SLE Workshop at Hospital for Special Surgery. https://www.hss.edu/conditions_understanding-laboratory-tests-and-results-for-systemic-lupus-erythematosus.asp. [diakses tanggal 11 Agustus 2016].

Bloch DB. (Online) 2019. The anti-Ro/SSA and ant-La/SSB Antigen – antibody Systems. https://www.uptodate.com/contents/the-anti-ro-ssa-and-anti-la-ssb-antigen-antibody-systems. [diakses tanggal 21 Juni 2020].

O’Sullivan M, McLean-Tooke A, Loh RKS. 2013. Antinuclear antibody test. Australian Family Physician. 42(10):718-721.

Lab Tests Online. (Online) 2017. Extractable nuclear antigen antibodies (ENA) Panel. Washington DC: Lab Test Online AACC. www.labtestonline.org. [diakses tanggal 7 Agustus 2017].

Mayo Foundation for Medical Education and Research. (Online) 2017. Antibody to extractable nuclear antigen evaluation serum. Rochester: Mayo Clinic Laboratories. www.mayomedicallaboratories.com. [diakses tanggal 11 Agustus 2016].

Euroimun a PerkinElmer company insert kit. (Online) 2017. Anti-dsDNA radioimmunoassay (IgA/IGG/IgM). Lübeck: Euroimmun. www.euroimmun.com [diakses tanggal 7 Agustus 2016].

Bloch DB. (Online) 2019. Measurement and clinical significance of antinuclear antibodies. https://www.uptodate.com/contents/measurement-and-clinical-significance-of-antinuclear-antibodies. [diakses tanggal 21 Juni 2020].

Bloch DB. (Online) 2020. Clinical significance of antinuclear antibody staining patterns and associated autoantibodies. https://www.uptodate.com/contents/clinical-significance-of-antinuclear-antibody-staining-patterns-and-associated-autoantibodies. [diakses tanggal 15 Juli 2020].

Kavanaugh AF, Solomon DH, American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines. 2002. Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests. Arthritis & Rheumatology. 47(5):546-555.

Liu CC, Manzi S, Ahearn JM. 2005. Biomarkers for systemic lupus erythematosus: a review and perspective. Current Opinion in Rheumatology. 17(5):543-549.

Kumar Y, Bhatia A, Minz RW. 2009. Antinuclear antibodies and their detection methods in diagnostics connective tissue diseases: a journey revisited. Diagnostic Pathology. 4: 1.

Migliorini P, Baldini C, Rocchi V, Bombardieri S. 2005. Anti-Sm and anti-RNP antibodies. Autoimmunity. 38(1):47-54.

Wallace JD. (Online) 2020. Overview the management and prognosis of systemic lupus erythematosus. https://www.uptodate.com/contents/overview-of-the-management-and-prognosis-of-systemic-lupus-erythematosus-in-adults. [diakses tanggal 15 Juli 2020].

Lee WS dan Amengual O. 2020. B cells targeting therapy in the management of systemic lupus erythematosus. Immunological Medicine. 43(1):16-35.




DOI: https://doi.org/10.32502/sm.v11i2.2788

Refbacks

  • There are currently no refbacks.


Copyright (c) 2021 May Fanny Tanzilia, Betty Agustina Tambunan, Desak Nyoman Surya Suaemitria Dewi

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

   

Statistic counter 

sinta4